Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Estrogen Receptor Positive Breast Cancer 1

Interventions

pembrolizumab 524 Specimen Handling 383 Carboplatin 377 Magnetic Resonance Spectroscopy 336 Cisplatin 332 Nivolumab 308 Cyclophosphamide 298 Radiotherapy 257 Paclitaxel 255 Gemcitabine 235 Biopsy 235 Bevacizumab 218 Dexamethasone 169 durvalumab 168 Oxaliplatin 163 Capecitabine 158 Rituximab 157 Fluorouracil 149 venetoclax 147 Docetaxel 147 Etoposide 142 Drug Therapy 142 atezolizumab 141 Doxorubicin 134 Ipilimumab 129 Radiosurgery 120 Prednisone 120 Lenalidomide 119 Leucovorin 113 fludarabine 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Estrogens × 1 year × Clear all

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡